The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Open accessAbstract
Increased expression of zinc finger E-box binding homeobox 1 (ZEB1) is associated with tumor grade and metastasis in lung cancer, likely due to its role as a transcription factor in epithelial-to-mesenchymal transition (EMT). Here, we modeled malignant transformation in human bronchial epithelial cells (HBECs) and determined that EMT and ZEB1 expression are early, critical events in lung cancer pathogenesis. Specific oncogenic mutations in TP53 and KRAS were required for HBECs to engage EMT machinery in response to microenvironmental (serum/TGF-β) or oncogenetic (MYC) factors. Both TGF-β- and MYC-induced EMT required ZEB1, but engaged distinct TGF-β-dependent and vitamin D receptor-dependent (VDR-dependent) pathways, respectively. Functionally, we found that ZEB1 causally promotes malignant progression of HBECs and tumorigenicity, invasion, and metastases in non-small cell lung cancer (NSCLC) lines. Mechanistically, ZEB1 expression in HBECs directly repressed epithelial splicing regulatory protein 1 (ESRP1), leading to increased expression of a mesenchymal splice variant of CD44 and a more invasive phenotype. In addition, ZEB1 expression in early stage IB primary NSCLC correlated with tumor-node-metastasis stage. These findings indicate that ZEB1-induced EMT and associated molecular changes in ESRP1 and CD44 contribute to early pathogenesis and metastatic potential in established lung cancer. Moreover, TGF-β and VDR signaling and CD44 splicing pathways associated with ZEB1 are potential EMT chemoprevention and therapeutic targets in NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,190
Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., D’Alessio, A. C., Young, R. A., & Weinberg, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.06.005 · Cited by 876
Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102028 · Cited by 802
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Jiang, F., Qiu, Q., Khanna, A., Todd, N. W., Deepak, J., Xing, L., Wang, H., Liu, Z., Su, Y., Stass, S. A., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0393 · Cited by 788
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 617
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3703 · Cited by 607
Self-citationThe Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D., Eger, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5682 · Cited by 532
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Sánchez-Tilló, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1122-2 · Cited by 518
Global mapping of c-Myc binding sites and target gene networks in human B cells
Zeller, K. I., Zhao, X., Lee, C. W. H., Chiu, K. P., Yao, F., Yustein, J. T., Ooi, H. S., Orlov, Y. L., Shahab, A., Yong, H. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604129103 · Cited by 516
Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 512
Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., & Sporn, M. B. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380112 · Cited by 444
Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., Schuster, K., Shao, C., Larsen, J. E., Sullivan, L. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0881 · Cited by 416
Self-citationAn ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition
Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., & Carstens, R. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.195 · Cited by 383
NCI-navy medical oncology branch cell line data base
Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Carney, D., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630505 · Cited by 303
Self-citationDohadwala, M., Yang, S.-C., Luo, J., Sharma, S., Batra, R. K., Huang, M., Lin, Y., Goodglick, L., Krysan, K., Fishbein, M. C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3635 · Cited by 282
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2521 · Cited by 263
Self-citationMolecular Biology of Lung Cancer: Clinical Implications
Larsen, J. E., & Minna, J. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.003 · Cited by 245
Self-citationDesign and properties of a Myc derivative that efficiently homodimerizes
Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., & Nasi, S. (1998) · Oncogene · doi:10.1038/sj.onc.1202199 · Cited by 221
Molecular biology of lung cancer: Clinical implications
Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 209
Self-citationTGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi, A., Miyazawa, K., Miyazono, K., et al. (2012) · Oncogene · doi:10.1038/onc.2011.493 · Cited by 209
Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
Sato, M., Larsen, J. E., Lee, W., Sun, H., Shames, D. S., Dalvi, M. P., Ramirez, R. D., Tang, H., DiMaio, J. M., Gao, B., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0634-t · Cited by 205
Self-citationWNT7a induces E-cadherin in lung cancer cells
Ohira, T., Gemmill, R. M., Ferguson, K., Kusy, S., Roche, J., Brambilla, E., Zeng, C., Baron, A., Bemis, L., Erickson, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734137100 · Cited by 182
ZEB1-responsive genes in non-small cell lung cancer
Gemmill, R. M., Roche, J., Potiron, V. A., Nasarre, P., Mitas, M., Coldren, C. D., Helfrich, B. A., Garrett-Mayer, E., Bunn, P. A., & Drabkin, H. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.09.007 · Cited by 179
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Ahn, Y., Gibbons, D. L., Chakravarti, D., Creighton, C. J., Rizvi, Z. H., Adams, H. P., Pertsemlidis, A., Gregory, P. A., Wright, J. A., Goodall, G. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63608 · Cited by 162
Takeyama, Y., Sato, M., Horio, M., Hase, T., Yoshida, K., Yokoyama, T., Nakashima, H., Hashimoto, N., Sekido, Y., Gazdar, A. F., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.008 · Cited by 159
Self-citationCancer stem cells in lung cancer: Evidence and controversies
Alamgeer, M., Peacock, C. D., Matsui, W. H., Ganju, V., & Watkins, D. N. (2013) · Respirology · doi:10.1111/resp.12094 · Cited by 158
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
Yang, Y., Ahn, Y., Chen, Y., Tan, X., Guo, L., Gibbons, D. L., Ungewiss, C., Peng, D. H., Liu, X., Lin, S. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72171 · Cited by 121
Self-citationSnail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma
Yanagawa, J., Walser, T. C., Zhu, L. X., Hong, L., Fishbein, M. C., Mah, V. H., Chia, D., Goodglick, L., Elashoff, D. A., Luo, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1558 · Cited by 119
Depletion of TGF-β from fetal bovine serum
Oida, T., & Weiner, H. L. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.09.008 · Cited by 110
Osborne, J. K., Larsen, J. E., Shields, M. D., Gonzales, J. X., Shames, D. S., Sato, M., Kulkarni, A., Wistuba, I. I., Girard, L., Minna, J. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303932110 · Cited by 106
Self-citationRole of microRNAs in the Regulation of Breast Cancer Stem Cells
Liu, S., Clouthier, S. G., & Wicha, M. S. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9242-8 · Cited by 101
Roche, J., Nasarre, P., Gemmill, R. M., Baldys, A., Pontis, J., Korch, C. T., Guilhot, J., Ait‐Si‐Ali, S., & Drabkin, H. A. (2013) · Cancers · doi:10.3390/cancers5020334 · Cited by 84
Proteomic profiling of Myc-associated proteins
Agrawal, P., Yu, K., Salomon, A. R., & Sedivy, J. M. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14199 · Cited by 76
Fang, Y., Wei, J., Cao, J., Zhao, H., Liao, B., Qiu, S., Wang, D., Luo, J., & Chen, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062558 · Cited by 76
Interaction of vitamin D with membrane-based signaling pathways
Larriba, M. J., González‐Sancho, J. M., Bonilla, F., & Múñoz, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00060 · Cited by 72
Greer, R. M., Peyton, M., Larsen, J. E., Girard, L., Xie, Y., Gazdar, A. F., Harran, P. G., Wang, L., Brekken, R. A., Wang, X., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3947 · Cited by 61
Self-citationPrognostic significance of CD44s expression in resected non-small cell lung cancer
Ko, Y. H., Won, H. S., Jeon, E. K., Hong, S. H., Roh, S. Y., Hong, Y. S., Byun, J. H., Jung, C. K., & Kang, J. H. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-340 · Cited by 43
Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma
Zhang, J., Lu, C., Kang, J., Kang, J., Cao, C., & Li, M. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2136-4 · Cited by 42
Liu, Y., Zhang, N., Wang, Y., Xu, M., Liu, N., Pang, X., Cao, J. G., Ma, N., Pang, H., Liu, L., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02347.x · Cited by 41
Cited by
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
RNA-binding proteins in tumor progression
Qin, H., Ni, H., Liu, Y., Yuan, Y., Xi, T., Li, X., & Zheng, L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00927-w · Cited by 375
Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Zhang, N., Ng, A. S., Cai, S., Li, Q., Yang, L., & Kerr, D. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00343-0 · Cited by 349
Pleiotropic Roles for ZEB1 in Cancer
Caramel, J., Ligier, M., & Puisieux, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2476 · Cited by 344
Metadata
- Authors
- Larsen, J. E., Nathan, V., Osborne, J. K., Farrow, R. K., Deb, D., Sullivan, J. P., Dospoy, P. D., Augustyn, A., Hight, S. K., Sato, M., Girard, L., Behrens, C., Wistuba, I. I., Gazdar, A. F., Hayward, N. K., & Minna, J. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-08-08
- Volume
- 126
- Issue
- 9
- Pages
- 3219-3235
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2478110905
- Cited by
- 334
- References
- 53
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.